CCR6 Is a Prognostic Marker for Overall Survival in Patients with Colorectal Cancer, and Its Overexpression Enhances Metastasis In Vivo

The chemokine receptor CCR6 has been recently shown to be associated with colorectal cancer (CRC) progression. However, the direct evidence for whether CCR6 in tumors is a prognostic marker for the survival of patients with CRC and whether it plays a critical role in CRC metastasis in vivo is lackin...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jinlin, Ke, Fang, Xu, Zhenyao, Liu, Zhaoyuan, Zhang, Lingyun, Yan, Sha, Wang, Zhe, Wang, Hong, Wang, Honglin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076197/
https://www.ncbi.nlm.nih.gov/pubmed/24979261
http://dx.doi.org/10.1371/journal.pone.0101137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076197/
https://www.ncbi.nlm.nih.gov/pubmed/24979261
http://dx.doi.org/10.1371/journal.pone.0101137

Ejemplares similares